- Home
- EXEL vs EHC Comparison
EXEL vs EHC Comparison
Compare EXEL & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- EHC
- Stock Information
- Founded
- EXEL 1994
- EHC 1983
- Country
- EXEL United States
- EHC United States
- Employees
- EXEL 1147
- EHC N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- EHC Hospital/Nursing Management
- Sector
- EXEL Health Care
- EHC Health Care
- Exchange
- EXEL Nasdaq
- EHC Nasdaq
- Market Cap
- EXEL 10.4B
- EHC 12.3B
- IPO Year
- EXEL 2000
- EHC 1986
- Fundamental
- Price
- EXEL $38.31
- EHC $120.35
- Analyst Decision
- EXEL Buy
- EHC Strong Buy
- Analyst Count
- EXEL 21
- EHC 6
- Target Price
- EXEL $43.65
- EHC $132.83
- AVG Volume (30 Days)
- EXEL 4.0M
- EHC 942.9K
- Earning Date
- EXEL 07-28-2025
- EHC 08-04-2025
- Dividend Yield
- EXEL N/A
- EHC 0.63%
- EPS Growth
- EXEL 81.76
- EHC 30.39
- EPS
- EXEL 2.08
- EHC 5.11
- Revenue
- EXEL $2,230,005,000.00
- EHC $5,669,100,000.00
- Revenue This Year
- EXEL $9.88
- EHC $10.75
- Revenue Next Year
- EXEL $12.59
- EHC $8.59
- P/E Ratio
- EXEL $18.45
- EHC $23.48
- Revenue Growth
- EXEL 10.73
- EHC 11.80
- 52 Week Low
- EXEL $25.12
- EHC $87.36
- 52 Week High
- EXEL $49.62
- EHC $123.13
- Technical
- Relative Strength Index (RSI)
- EXEL 41.08
- EHC 67.54
- Support Level
- EXEL $37.01
- EHC $116.90
- Resistance Level
- EXEL $38.78
- EHC $118.48
- Average True Range (ATR)
- EXEL 1.12
- EHC 2.42
- MACD
- EXEL 0.07
- EHC 1.30
- Stochastic Oscillator
- EXEL 83.79
- EHC 97.29
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.